Watchlist Price Alert

Novartis AG (NVS)

NYSE: NVS · Real-Time Price · USD

115.75

3.17 (2.82%)

At close: May 30, 2025, 3:59 PM

115.85

0.09%

After-hours: May 30, 2025, 05:29 PM EDT

Novartis Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	51.72B	46.66B	51.83B	52.88B	49.9B	48.68B	53.17B	50.13B	49.44B
Cost of Revenue	12.83B	12.47B	15.49B	15.87B	15.12B	14.43B	18.41B	17.18B	17.52B
Gross Profit	38.9B	34.19B	36.34B	37.01B	34.78B	34.25B	34.76B	32.96B	31.92B
Operating Income	14.54B	9.77B	9.2B	26.95B	10.15B	9.09B	8.17B	8.63B	8.27B
Interest Income	568M	627M	379M	71M	91M	245M	294M	110M	43M
Pretax Income	13.64B	9.12B	8.37B	26.14B	9.88B	8.94B	13.84B	9B	7.82B
Net Income	11.94B	14.85B	6.96B	24.02B	8.07B	7.15B	12.61B	7.7B	6.71B
Selling & General & Admin	12.57B	12.49B	14.25B	14.89B	14.2B	14.37B	16.47B	15B	14.19B
Research & Development	10.02B	11.37B	10B	9.54B	8.98B	9.4B	9.07B	8.97B	9.04B
Other Expenses	1.76B	559M	2.9B	895M	1.45B	1.4B	1.04B	362M	417M
Operating Expenses	24.35B	24.42B	27.14B	25.32B	24.63B	25.17B	26.59B	24.33B	23.65B
Interest Expense	1.01B	855M	837M	811M	869M	850M	957M	777M	707M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	12.86B	12B
Cost & Expenses	37.18B	36.89B	42.63B	41.19B	39.75B	39.59B	45B	41.51B	41.17B
Income Tax Expense	1.7B	551M	1.42B	2.12B	1.81B	1.79B	1.22B	1.3B	1.12B
Shares Outstanding (Basic)	2.02B	2.08B	2.18B	2.24B	2.28B	2.29B	2.32B	2.35B	2.38B
Shares Outstanding (Diluted)	2.04B	2.09B	2.2B	2.26B	2.3B	2.32B	2.34B	2.37B	2.4B
EPS (Basic)	5.92	7.15	3.19	10.71	3.54	3.12	5.44	3.28	2.82
EPS (Diluted)	5.87	7.10	3.17	10.63	3.52	3.08	5.38	3.25	2.80
EBITDA	20.71B	18.29B	14.73B	17.13B	15.24B	15.01B	14.13B	13.9B	13.19B
EBIT	14.65B	9.98B	7.98B	11.7B	10.15B	9.09B	15.03B	8.69B	9.09B
Depreciation & Amortization	6.07B	8.28B	6.71B	5.43B	5.11B	5.83B	5.21B	5.21B	5.35B